-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Statera Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2021.
- Statera Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$3.76M, a 45.1% decline year-over-year.
- Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$28.2M, a 455% decline from 2020.
- Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$5.08M, a 90.8% decline from 2019.
- Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2019 was -$2.66M, a 42.3% increase from 2018.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)